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Many interesting studies have been selected for presentation in the 2013 edition of the
‘‘Congrès médicochirurgical de la ﬁliale de cardiologie pédiatrique et congénitale de la
Société franc¸aise de pédiatrie’’. The variety of these studies highlights the wide range
of research subjects involved in pediatric and congenital cardiology. We are still learn-
ing from collaborative works reporting anatomical and epidemiological features, as well
as therapeutic options, of rare diseases. New diagnostic tools are emerging with ongoing
technological progress in imaging, such as echocardiography (speckle tracking, tridimen-
sional, miniaturized transoesophageal ultrasound) and MRI. Transcatheter treatments are
now the primary choice for several shunts, or are getting integrated in therapeutic strate-
gies for complex diseases such as tetralogy of Fallot and single ventricle. The age range of
congenital cardiac patients is getting wider, which means that it is as important to opti-
mize foetal and perinatal care, as it is to develop GUCH cardiology dedicated to young
adults. As survival has considerably improved over the past decades, we need more stud-
ies to assess the quality of life, education, and social integration of young patients with
congenital heart disease. Another challenge of pediatric and congenital cardiology is the
treatment of end-stage heart failure when all ‘‘conventional’’ therapeutic options have
failed. In this highly fatal condition, survival is improving thanks to innovating inotropic
drugs, miniaturized ventricular assist devices, as well as constantly improving results of
heart transplant in young children. In the future, cell therapy may become an alternative
to heart transplant to restore cardiac function.
Our hope was that this edition would fully reﬂect the plurality and the dynamism
of research in our discipline. Thanks to the quality of the submitted works, mission is
accomplished.Disclosure of interest
The authors declare that they have no conﬂicts of interest concerning this article.
∗ Corresponding author. Fax: +33 2 40 08 78 73.
E-mail addresses: veronique.gournay@chu-nantes.fr (V. Gournay), patrice.guerin@chu-nantes.fr (P. Guérin).
875-2136/$ — see front matter © 2013 Elsevier Masson SAS. All rights reserved.
ttp://dx.doi.org/10.1016/j.acvd.2013.06.003
